Pharmacologic management of asymptomatic bacteriuria and urinary tract infections in women.

OB/GYN Department, UMass Memorial Medical Center, University of Massachusetts, 119 Belmont Street,Worcester, MA 01605, USA.
Journal of midwifery & women's health (Impact Factor: 1.13). 05/2011; 56(3):248-65. DOI: 10.1111/j.1542-2011.2011.00063.x
Source: PubMed

ABSTRACT Many factors influence the decision to institute treatment for the common problems of urinary tract symptoms and/or the presence of microorganisms in the urine of women. This article summarizes current evidence related to treatment choice and compares selected treatment practice guidelines. Evidence related to prevention of recurrent infection without the use of antibiotics is included.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Women who have delivered an infant between 16 and 36 weeks' gestation have an increased risk of preterm birth (PTB) in a subsequent pregnancy. The high incidence of recurrent PTB remains relatively unchanged despite intensive research efforts and advances in perinatal care. Attempts to decrease the incidence of recurrent PTB have not always been successful, with research efforts being focused on clinical, pharmacotherapy and biochemical, and ultrasound strategies. Fortunately, there is adequate evidence in the literature to justify clinical management guidelines that may impact the PTB rate: smoking cessation, treatment of asymptomatic bacteriuria, transvaginal ultrasonography of the cervix, administration of vaginal progesterone or 17α-hydroxyprogesterone caproate, cerclage, and fetal fibronectin. This article is intended to give brief highlights of these strategies and the current science that supports their conclusions.
    The Journal of perinatal & neonatal nursing 07/2012; 26(3):220-9. · 0.81 Impact Factor